Analystreport

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $108.00 price target on the stock.

Axsome Therapeutics, Inc.  (AXSM) 
Last axsome therapeutics, inc. earnings: 3/12 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: axsome.com